Current advances in sustained-release systems for parenteral drug delivery
暂无分享,去创建一个
Yi Shi | Yi Shi | Lukchiu Li | Luk Li
[1] T. Kissel,et al. Branched biodegradable polyesters for parenteral drug delivery systems. , 2000, Journal of controlled release : official journal of the Controlled Release Society.
[2] J. Feijen,et al. In vivo and in vitro degradation of poly(ether ester) block copolymers based on poly(ethylene glycol) and poly(butylene terephthalate). , 2004, Biomaterials.
[3] Yi Yan Yang,et al. Effect of polymer compositions on the fabrication of poly(ortho‐ester) microspheres for controlled release of protein , 2001 .
[4] Sweta Modi,et al. Role of polyanhydrides as localized drug carriers. , 2005, Journal of controlled release : official journal of the Controlled Release Society.
[5] T. Hagen. Liposomal cytokines in the treatment of infectious diseases and cancer. , 2005 .
[6] J. Feijen,et al. Microspheres for protein delivery prepared from amphiphilic multiblock copolymers. 2. Modulation of release rate. , 2000, Journal of controlled release : official journal of the Controlled Release Society.
[7] H. Bunjes,et al. Physicochemical characterization of lipid nanoparticles and evaluation of their drug loading capacity and sustained release potential , 1997 .
[8] N. Elvassore,et al. Production of Protein-Loaded Polymeric Microcapsules by Compressed CO2 in a Mixed Solvent , 2001 .
[9] Sung Wan Kim,et al. Controlled Release of Insulin from Injectable Biodegradable Triblock Copolymer Depot in ZDF Rats , 2003, Pharmaceutical Research.
[10] N. Oku,et al. Glucuronate-modified, long-circulating liposomes for the delivery of anticancer agents. , 2005, Methods in enzymology.
[11] Martyn C. Davies,et al. Supercritical fluid mixing: preparation of thermally sensitive polymer composites containing bioactive materials , 2001 .
[12] J. Zhang,et al. Development and characterization of a novel Cremophor EL free liposome-based paclitaxel (LEP-ETU) formulation. , 2005, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.
[13] D. Crommelin,et al. Liposomes as sustained release system for human interferon-gamma: biopharmaceutical aspects. , 2001, Biochimica et biophysica acta.
[14] J. Cleland,et al. Sustained delivery of human growth hormone from a novel gel system: SABER. , 2002, Biomaterials.
[15] M. Radomsky,et al. Sustained-Release Injectable Products , 2000 .
[16] T. Kissel,et al. In situ forming parenteral drug delivery systems: an overview. , 2004, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.
[17] Lukchiu Li,et al. Formulation and characterization of bupivacaine lipospheres. , 2004, International journal of pharmaceutics.
[18] W. Hennink,et al. IL-2 loaded dextran microspheres with attractive histocompatibility properties for local IL-2 cancer therapy. , 2003, Cytokine.
[19] M Morlock,et al. Erythropoietin loaded microspheres prepared from biodegradable LPLG-PEO-LPLG triblock copolymers: protein stabilization and in-vitro release properties. , 1998, Journal of controlled release : official journal of the Controlled Release Society.
[20] Chun Xing Li. Poly(L-glutamic acid)--anticancer drug conjugates. , 2002, Advanced drug delivery reviews.
[21] Dennis Stephens,et al. Polyanhydride implant for antibiotic delivery--from the bench to the clinic. , 2002, Advanced drug delivery reviews.
[22] G. Gregoriadis,et al. The effect of polysialylation on the immunogenicity and antigenicity of asparaginase: implication in its pharmacokinetics. , 2001, International journal of pharmaceutics.
[23] J. Heller,et al. Biochronomer™ technology , 2005, Expert opinion on drug delivery.
[24] S. Lehnert,et al. A novel non-toxic camptothecin formulation for cancer chemotherapy. , 2005, Biomaterials.
[25] A. Gabizon. Selective tumor localization and improved therapeutic index of anthracyclines encapsulated in long-circulating liposomes. , 1992, Cancer research.
[26] D. Drucker,et al. Development and characterization of a glucagon-like peptide 1-albumin conjugate: the ability to activate the glucagon-like peptide 1 receptor in vivo. , 2003, Diabetes.
[27] Jan Feijen,et al. Poly(ethylene oxide)/poly(butylene terephthalate) segmented block copolymers: the effect of copolymer composition on physical properties and degradation behavior , 2001 .
[28] W. Hennink,et al. Release of recombinant human interleukin-2 from dextran-based hydrogels. , 2002, Journal of controlled release : official journal of the Controlled Release Society.
[29] R. Gurny,et al. Release of BSA from poly(ortho ester) extruded thin strands. , 2001, Journal of controlled release : official journal of the Controlled Release Society.
[30] K. Avgoustakis,et al. Biodistribution properties of nanoparticles based on mixtures of PLGA with PLGA-PEG diblock copolymers. , 2005, International journal of pharmaceutics.
[31] R B Greenwald,et al. PEG drugs: an overview. , 2001, Journal of controlled release : official journal of the Controlled Release Society.
[32] James C. Wright,et al. Long-Term Controlled Delivery of Therapeutic Agents via an Implantable Osmotically Driven System: The DUROS Implant , 2002 .
[33] J. Shah,et al. Efficacy and Pharmacokinetics of Site-Specific Cefazolin Delivery Using Biodegradable Implants in the Prevention of Post-operative Wound Infections , 1998, Pharmaceutical Research.
[34] Jingshe Song,et al. Effect of Solid State Transition on the Physical Stability of Suspensions Containing Bupivacaine Lipid Microparticles , 2005, Pharmaceutical development and technology.
[35] J. Benoit,et al. Microencapsulation of protein particles within lipids using a novel supercritical fluid process. , 2002, International journal of pharmaceutics.
[36] Y. Tsutsumi,et al. Selective enhancement of thrombopoietic activity of PEGylated interleukin 6 by a simple procedure using a reversible amino‐protective reagent , 2001, British journal of haematology.
[37] T. Kissel,et al. Parenteral protein delivery systems using biodegradable polyesters of ABA block structure, containing hydrophobic poly(lactide-co-glycolide) A blocks and hydrophilic poly(ethylene oxide) B blocks , 1996 .
[38] D. Collen,et al. Clinical development of PEGylated recombinant staphylokinase (PEG-Sak) for bolus thrombolytic treatment of patients with acute myocardial infarction. , 2003, Advanced drug delivery reviews.
[39] S. B. Tiwari,et al. Potential Applications of Polymeric Microsphere Suspension as Subcutaneous Depot for Insulin , 2003, Drug development and industrial pharmacy.
[40] Helmut Hahn,et al. Atovaquone Nanosuspensions Show Excellent Therapeutic Effect in a New Murine Model of Reactivated Toxoplasmosis , 2001, Antimicrobial Agents and Chemotherapy.
[41] G. Storm,et al. Liposomes for Local Sustained Drug Release , 2000 .
[42] Richard B Greenwald,et al. Effective drug delivery by PEGylated drug conjugates. , 2003, Advanced drug delivery reviews.
[43] L. Zarif,et al. Elongated supramolecular assemblies in drug delivery. , 2002, Journal of controlled release : official journal of the Controlled Release Society.
[44] M. Woodle,et al. Controlling liposome blood clearance by surface-grafted polymers. , 1998, Advanced drug delivery reviews.
[45] Hanry Yu,et al. Polyphosphoester microspheres for sustained release of biologically active nerve growth factor. , 2002, Biomaterials.
[46] H. Maeda,et al. Mechanism of tumor-targeted delivery of macromolecular drugs, including the EPR effect in solid tumor and clinical overview of the prototype polymeric drug SMANCS. , 2001, Journal of controlled release : official journal of the Controlled Release Society.
[47] Abraham J Domb,et al. Polyanhydrides: an overview. , 2002, Advanced drug delivery reviews.
[48] M. Bally,et al. Preparation, characterization, and biological analysis of liposomal formulations of vincristine. , 2005, Methods in enzymology.
[49] A. Cheung,et al. Inhibition of neointimal hyperplasia in vascular grafts by sustained perivascular delivery of paclitaxel. , 2004, Kidney international.
[50] Hua Yang,et al. Biodegradable poly(epsilon-caprolactone)-poly(ethylene glycol) block copolymers: characterization and their use as drug carriers for a controlled delivery system. , 2003, Biomaterials.
[51] G. Andriole,et al. Safety and efficacy of an implantable leuprolide delivery system in patients with advanced prostate cancer. , 2000, The Journal of urology.
[52] Y. Y. Yang,et al. POE-PEG-POE triblock copolymeric microspheres containing protein. I. Preparation and characterization. , 2001, Journal of controlled release : official journal of the Controlled Release Society.
[53] S. Kleppner,et al. Implantable technology for long-term delivery of nalmefene for treatment of alcoholism. , 2004, International journal of pharmaceutics.
[54] J. Benoit,et al. Baclofen-loaded microspheres: preparation and efficacy testing in a new rabbit model. , 2005, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.
[55] L. Webster,et al. Relative analgesic potency of fentanyl and sufentanil during intermediate-term infusions in patients after long-term opioid treatment for chronic pain , 2004, Pain.
[56] W. Hennink,et al. Degradable dextran hydrogels: controlled release of a model protein from cylinders and microspheres. , 1999, Journal of controlled release : official journal of the Controlled Release Society.
[57] N. Elvassore,et al. Production of insulin-loaded poly(ethylene glycol)/poly(l-lactide) (PEG/PLA) nanoparticles by gas antisolvent techniques. , 2001, Journal of pharmaceutical sciences.
[58] James M. Anderson,et al. Biocompatibility of ABA triblock copolymer microparticles consisting of poly(l-lactic-co-glycolic-acid) A-blocks attached to central poly(oxyethylene) B-blocks in rats after intramuscular injection , 1997 .
[59] S. Brosman,et al. An open-label study of abarelix in men with symptomatic prostate cancer at risk of treatment with LHRH agonists. , 2003, Urology.
[60] J. Mestecky,et al. Biodegradable block copolymers for delivery of proteins and water-insoluble drugs. , 2001, Journal of controlled release : official journal of the Controlled Release Society.
[61] K. Walter,et al. Polilactofate microspheres for Paclitaxel delivery to central nervous system malignancies. , 2003, Clinical cancer research : an official journal of the American Association for Cancer Research.
[62] O. Sartor. Eligard: leuprolide acetate in a novel sustained-release delivery system. , 2003, Urology.
[63] E Harper,et al. Enhanced efficacy of a novel controlled release paclitaxel formulation (PACLIMER delivery system) for local-regional therapy of lung cancer tumor nodules in mice. , 1999, Clinical cancer research : an official journal of the American Association for Cancer Research.
[64] O. Pérez,et al. Proteoliposome derived cochleate as novel adjuvant. , 2006, Vaccine.
[65] E. Schacht,et al. Development of a poly(ortho ester) prototype with a latent acid in the polymer backbone for 5-fluorouracil delivery. , 2000, Journal of controlled release : official journal of the Controlled Release Society.
[66] F. Veronese. Peptide and protein PEGylation: a review of problems and solutions. , 2001, Biomaterials.
[67] G. Gregoriadis,et al. Polysialic acids: potential in drug delivery , 1993, FEBS letters.
[68] L. Barbu-Tudoran,et al. Design of Amine-Modified Graft Polyesters for Effective Gene Delivery Using DNA-Loaded Nanoparticles , 2004, Pharmaceutical Research.
[69] Mathias Winterhalter,et al. Stealth® liposomes: from theory to product , 1997 .
[70] Kinam Park,et al. A new microencapsulation method using an ultrasonic atomizer based on interfacial solvent exchange. , 2004, Journal of controlled release : official journal of the Controlled Release Society.
[71] W. Hennink,et al. In vitro biocompatibility of biodegradable dextran-based hydrogels tested with human fibroblasts. , 2001, Biomaterials.
[72] B. Chertin,et al. An implant releasing the gonadotropin hormone-releasing hormone agonist histrelin maintains medical castration for up to 30 months in metastatic prostate cancer. , 2000, The Journal of urology.
[73] G. Gregoriadis,et al. Improving the therapeutic efficacy of peptides and proteins: a role for polysialic acids. , 2005, International journal of pharmaceutics.
[74] Robert Gurny,et al. Poly(ortho esters): synthesis, characterization, properties and uses. , 2002, Advanced drug delivery reviews.
[75] S. Mantripragada. A lipid based depot (DepoFoam technology) for sustained release drug delivery. , 2002, Progress in lipid research.
[76] Lukchiu Li,et al. In Vitro Characterization of Polyorthoester Microparticles Containing Bupivacaine , 2003, Pharmaceutical development and technology.
[77] Cleland,et al. Recombinant human growth hormone poly(lactic-co-glycolic acid) microsphere formulation development. , 1997, Advanced drug delivery reviews.
[78] D. Radulescu,et al. Uniform Paclitaxel-Loaded Biodegradable Microspheres Manufactured by Ink-Jet Technology. , 2003 .
[79] P. Caliceti,et al. Pharmacokinetic and biodistribution properties of poly(ethylene glycol)-protein conjugates. , 2003, Advanced drug delivery reviews.
[80] P. Caliceti,et al. PEGylation of growth hormone-releasing hormone (GRF) analogues. , 2003, Advanced drug delivery reviews.
[81] K. Jacobson,et al. Cochleate lipid cylinders: formation by fusion of unilamellar lipid vesicles. , 1975, Biochimica et biophysica acta.
[82] V. Sinha,et al. Biodegradable microspheres for protein delivery. , 2003, Journal of controlled release : official journal of the Controlled Release Society.
[83] G. Gregoriadis,et al. Polysialylated insulin: synthesis, characterization and biological activity in vivo. , 2003, Biochimica et biophysica acta.
[84] R. Duncan,et al. Dextrins as potential carriers for drug targeting: tailored rates of dextrin degradation by introduction of pendant groups. , 2001, International journal of pharmaceutics.
[85] Z. Gu,et al. In vitro degradation and controlled release behavior of D,L-PLGA50 and PCL-b-D,L-PLGA50 copolymer microspheres. , 2005, Journal of controlled release : official journal of the Controlled Release Society.
[86] J. Benoit,et al. Development of novel 5-FU-loaded poly(methylidene malonate 2.1.2)-based microspheres for the treatment of brain cancers. , 2004, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.
[87] J. M. Harris,et al. Improvements in protein PEGylation: pegylated interferons for treatment of hepatitis C. , 2001, Journal of controlled release : official journal of the Controlled Release Society.
[88] R. Kaushik,et al. Poly-ϵ-caprolactone microspheres and nanospheres: an overview , 2004 .
[89] J. Leroux,et al. Novel injectable neutral solutions of chitosan form biodegradable gels in situ. , 2000, Biomaterials.
[90] Y. Y. Yang,et al. POE-PEG-POE triblock copolymeric microspheres containing protein. II. Polymer erosion and protein release mechanism. , 2001, Journal of controlled release : official journal of the Controlled Release Society.
[91] V. Sinha,et al. Biodegradable PEGylated microspheres and nanospheres , 2004 .
[92] Constancis,et al. Macromolecular Colloids of Diblock Poly(amino acids) That Bind Insulin. , 1999, Journal of colloid and interface science.
[93] K. Leong,et al. A novel biodegradable gene carrier based on polyphosphoester. , 2001, Journal of the American Chemical Society.
[94] A. Domb,et al. Preparation and Characterization of Carmustine Loaded Polyanhydride Wafers for Treating Brain Tumors , 1999, Pharmaceutical Research.
[95] Chong-K. Kim,et al. Effect of sodium chloride on the gelation temperature, gel strength and bioadhesive force of poloxamer gels containing diclofenac sodium. , 2001, International journal of pharmaceutics.
[96] Y. Tsutsumi,et al. Enhanced antitumor potency of polyethylene glycolylated tumor necrosis factor-alpha: a novel polymer-conjugation technique with a reversible amino-protective reagent. , 1999, The Journal of pharmacology and experimental therapeutics.
[97] W. Hennink,et al. Equilibrium water content of microspheres based on cross-linked dextran. , 1999, International journal of pharmaceutics.
[98] W. E. Hennink,et al. Effect of polymerization conditions on the network properties of dex-HEMA microspheres and macro-hydrogels. , 2005, International journal of pharmaceutics.
[99] Willis,et al. Ligand-targeted liposomes. , 1998, Advanced drug delivery reviews.
[100] Horacio B Croxatto. Progestin implants , 2000, Steroids.
[101] T. Allen. Ligand-targeted therapeutics in anticancer therapy , 2002, Nature Reviews Cancer.
[102] T. Kissel,et al. Biodegradable brush-like graft polymers from poly(d,l-lactide) or poly(d,l-lactide-co-glycolide) and charge-modified, hydrophilic dextrans as backbone—Synthesis, characterization and in vitro degradation properties , 1997 .
[103] A. Göpferich,et al. Lipid microparticles as a parenteral controlled release device for peptides. , 2001, Journal of controlled release : official journal of the Controlled Release Society.
[104] Duu-Jong Lee,et al. Gentamicin-loaded discs and microspheres and their modifications: characterization and in vitro release. , 2005, Journal of controlled release : official journal of the Controlled Release Society.
[105] Mingshi Yang,et al. Preparation and characterization of melittin-loaded poly (DL-lactic acid) or poly (DL-lactic-co-glycolic acid) microspheres made by the double emulsion method. , 2005, Journal of controlled release : official journal of the Controlled Release Society.
[106] L. Zarif,et al. Pharmacokinetics and tissue distribution after intravenous administration of a single dose of amphotericin B cochleates, a new lipid-based delivery system. , 2002, Journal of pharmaceutical sciences.
[107] Imran Ahmad,et al. Development and characterization of a novel liposome-based formulation of SN-38. , 2004, International journal of pharmaceutics.
[108] L. Zarif. Drug delivery by lipid cochleates. , 2005, Methods in enzymology.
[109] C. Stevenson,et al. An in vivo/in vitro comparison with a leuprolide osmotic implant for the treatment of prostate cancer. , 2001, Journal of controlled release : official journal of the Controlled Release Society.
[110] W. Hennink,et al. The use of aqueous PEG/dextran phase separation for the preparation of dextran microspheres. , 1999, International journal of pharmaceutics.
[111] A. Gupte,et al. Formulation and characterization of Paclitaxel, 5-FU and Paclitaxel + 5-FU microspheres. , 2004, International journal of pharmaceutics.
[112] P. Sinko,et al. A hydrogel prepared by in situ cross-linking of a thiol-containing poly(ethylene glycol)-based copolymer: a new biomaterial for protein drug delivery. , 2003, Biomaterials.
[113] R. Mannino,et al. Cochleate Delivery Vehicles: Applications in Vaccine Delivery , 2000 .
[114] A. Göpferich,et al. Development and characterization of lipid microparticles as a drug carrier for somatostatin. , 2001, International journal of pharmaceutics.
[115] J. Shah,et al. Local Delivery of Vancomycin for the Prophylaxis of Prosthetic Device-Related Infections , 2005, Pharmaceutical Research.
[116] F. Dosio,et al. Preparation, characterization, cytotoxicity and pharmacokinetics of liposomes containing docetaxel. , 2003, Journal of controlled release : official journal of the Controlled Release Society.
[117] D. Attwood,et al. The Release of 5-Fluorouracil from Microspheres of Poly(ε-Caprolactone-co-ethylene Oxide) , 2000 .
[118] W. Saltzman,et al. Pharmacokinetics of the Carmustine Implant , 2002, Clinical pharmacokinetics.
[119] K. Shakesheff,et al. The production of protein-loaded microparticles by supercritical fluid enhanced mixing and spraying. , 2005, Journal of controlled release : official journal of the Controlled Release Society.
[120] J. Viret,et al. Liposomes and virosomes as delivery systems for antigens, nucleic acids and drugs. , 2004, Current opinion in biotechnology.
[121] B. Müller,et al. Characterization of co-polymers of lactic and glycolic acid for supercritical fluid processing. , 2000, Biomaterials.
[122] Q. Ye,et al. DepoFoam technology: a vehicle for controlled delivery of protein and peptide drugs. , 2000, Journal of controlled release : official journal of the Controlled Release Society.
[123] B. Gander,et al. Importance of single or blended polymer types for controlled in vitro release and plasma levels of a somatostatin analogue entrapped in PLA/PLGA microspheres. , 2004, Journal of controlled release : official journal of the Controlled Release Society.
[124] D. Grijpma,et al. In vitro degradation of Polyactive 1000PEOT70PBT30 devices. , 2002, Biomaterials.
[125] Robert Langer,et al. Poly(anhydrides). 3. Poly(anhydrides) based on aliphatic-aromatic diacids , 1989 .
[126] I. Goldberg,et al. Poloxamer 407-mediated alterations in the activities of enzymes regulating lipid metabolism in rats. , 2003, Journal of pharmacy & pharmaceutical sciences : a publication of the Canadian Society for Pharmaceutical Sciences, Societe canadienne des sciences pharmaceutiques.
[127] S. D'urso,et al. Lipid microparticles as sustained release system for a GnRH antagonist (Antide). , 2003, Journal of controlled release : official journal of the Controlled Release Society.
[128] Wenlei Jiang,et al. Biodegradable poly(lactic-co-glycolic acid) microparticles for injectable delivery of vaccine antigens. , 2005, Advanced drug delivery reviews.
[129] M. Whitlow,et al. Prolonged circulating lives of single-chain Fv proteins conjugated with polyethylene glycol: a comparison of conjugation chemistries and compounds. , 1999, Bioconjugate chemistry.
[130] J. Jansen,et al. Histological evaluation of a biodegradable Polyactive/hydroxyapatite membrane. , 1995, Biomaterials.
[131] I. Rubinstein,et al. Liposomal vasoactive intestinal peptide. , 2005, Methods in enzymology.